Ace Therapeutics Unveils End-to-End Pain Drug Development Solutions

Ace Therapeutics, a leading preclinical contract research organization based in New York, NY, has announced its comprehensive end-to-end solutions for advancing pain therapeutic development. The company specializes in preclinical analgesic drug development services, covering every stage from early target discovery to safety assessment. With a focus on scientific rigor and regulatory-compliant methodologies, Ace Therapeutics integrates in vitro and in vivo research platforms to study pain mechanisms, evaluate compound efficacy, and conduct safety profiling for novel analgesic candidates.

A core strength of Ace Therapeutics lies in its extensive portfolio of standardized and customized in vivo pain models for drug testing, spanning nearly all mainstream pain classifications. These validated animal models include migraine models established via trigeminal ganglion electrical stimulation or nitroglycerin induction, as well as neuropathic pain models such as spinal nerve ligation and chronic constriction injury. The company also offers systematic preclinical pain assessment services using methods like the Von Frey Filament Test, Hot Plate Test, and Formalin Test. In vitro models leverage dorsal root ganglion cells, iPSC-derived sensory neurons, and co-culture systems to explore cellular mechanisms, enhancing translational value.

Beyond model construction, Ace Therapeutics provides target-based and modality-based drug discovery services, supporting research on G-protein coupled receptors, cytokine networks, and ion channels for small-molecule analgesics, biologics, antibodies, and gene therapies. The full-service pipeline includes target validation, in vitro screening, in vivo pharmacology, pharmacokinetics, safety pharmacology, and biomarker discovery. Professional PK/PD modeling and toxicity assessment help clients reduce risks and accelerate candidate selection. For special needs, Ace Therapeutics designs customized pain models and assays. This comprehensive approach positions Ace Therapeutics as a key partner for global pharmaceutical and biotech companies aiming to develop novel analgesic drugs.